Public Markets 3 Days

Last updated: August 19, 2026, 11:40 PM ET

Asian Equities & IPOs

Indian IPO market activity is surging, with a gauge of recent BSE mainboard listings climbing 16% this year to a record high, while Japan's earnings posted their largest beat in five years, fueling hopes for a broad market rally beyond AI-related trades. Nikkei gains of 0.6% tracked Wall Street's overnight advances, and Asian stocks looked set to extend gains as Treasury buyback plans eased bond market stress. Canadian stocks jumped after President Trump delayed new 50% tariffs, while Tata Sons deferred its annual shareholder meeting due to quorum issues amid ongoing family control disputes. NSE valuation seeks up to $55 billion in its planned IPO, marking one of the largest listings in Indian market history.

Fixed Income & Currencies

Treasury buybacks will at least double to $4 billion per operation, with the dollar tumbling by the most in three weeks as long-dated yields retreated from multi-decade highs. Gold surged near $4,500 per ounce, its biggest gain in six months, while bond yields dropped as the Treasury signaled sustained intervention to calm markets. Treasury intervention has prompted comparisons to the Fed's 2011 Operation Twist, and long-bond ETF bets spiked a day before the announcement, raising questions about information flows. RBI's net short dollar position remains "very manageable," while Indian rupee and bond bets retreated as the dollar swap window closed early. PBOC set a weaker yuan fixing to slow currency gains after the yuan hit a three-year high, and Asian currencies remained mixed against the dollar. Yuan weakness signals China's desire to moderate appreciation pressure, while Zambia debt positions are turning bullish as Citi anticipates credit upgrades following recent elections. Treasury yields are expected to top 5% this year, with EM Asia bonds facing outflows as investors favor dollar assets. T-bill outlook is clouded by potentially limitless buybacks, and bond traders are eyeing junk-like yields on Microsoft-tied data center bonds.

Commodities & Energy

Corn futures broke the $5-a-bushel level for the first time in 18 months as US crop tour results pointed to tighter supplies, and raw sugar advanced to a 14-month high on global supply concerns. Oil prices edged higher amid lingering Middle East tensions, with crude oil stockpiles posting a third consecutive weekly increase of 4.4 million barrels. Saudi oil is offering full contractual volumes to European refiners, while tanker movements in the Strait of Hormuz have become erratic as Iran escalates control efforts. Black Sea grain shipments face attacks near Russian ports, and coking coal futures surged in China as supply tightens after mining accidents. Oil extends gains for a fourth straight session, with Iran tensions driving risk premiums higher across energy markets.

Banking & Financial Services

JPMorgan unit was banned by India's market regulator for alleged stock manipulation, while SK Hynix leveraged bet costs have halved after the chipmaker's US listing. Guggenheim loan whipsawed as lenders digested earnings calls, and private credit risks remain elevated following recent defaults. Barclays overhaul marks another leadership reshuffle less than three years since its last, and Monzo chair Gary Hoffman will step down months after a shareholder revolt. CPPIB departures across senior ranks have been reported, while healthcare private equity leadership changes signal sector shifts. Cantor access to Kalshi prediction markets is expanding to Wall Street clients, and hedge fund tax cuts in Hong Kong are sparking sector fears of talent exodus.

M&A & Corporate Deals

Stripe OpenRouter deal values the AI start-up at $7 billion, while Google Marvell struck a $12 billion AI chip partnership. CK Hutchison filed $1.5 billion arbitration against Panama, and JBS Pilgrim's Pride offered $1.2 billion for the remaining stake. BlackRock Oaktree seized a Hollywood servicer in a $900 million debt deal, while Carlyle Castelion joined a $1 billion investment round valuing the missile maker at $13 billion. Charlesbank WSHB nears a $700 million law firm acquisition, and Freenet Waipu.TV is close to buying out minority investors. Oasis Kakaku.com urged rejection of EQT's buyout bid, while Strategic Value APCOA considers a sale that could fetch €2-2.5 billion.

Economic Policy & Geopolitics

US debt hits $40 trillion as borrowing continues at a historic rate, and Treasury buybacks reflect Washington's concerns about rising borrowing costs. Bessent Treasury signaled willingness to intervene after yields hit two-decade highs, and Treasury watching bond market stress prompted action. Australia unemployment rose to 4.5%, prompting traders to pare rate-hike bets, while RBA rates may need to rise if inflation persists. UAE Iran announced a full trade embargo, and Iran tensions continue to drive energy market volatility. US-Canada trade pressures Mexico to match terms, and Trump tariffs pauses provided relief to Canadian markets. Crypto regulation calls intensify as Trump amasses crypto wealth, and Hyperliquid may move onshore under new regulatory signals.

Technology & Innovation

AIA growth of 13% in new business value led by Hong Kong and China sales, while Alibaba AI bets helped the tech giant reclaim investor favor. Google AI features heavily in the Pixel, though user reception remains uncertain, and AI compute futures are under CFTC consideration. Chinese rocket achieved first reusable landing, challenging SpaceX dominance, while SpaceX unlock creates new investor opportunities. Data center bonds offer junk-like yields amid AI infrastructure boom, and CoreWeave bonds are being tested by Goldman Sachs. Tech correction risks are rising, according to ECB economists, while tech stocks slid as bond selloffs continued.

Healthcare & Biotech

Moderna cancer vaccine success drove a 177% share surge, burning shorts with a $5.5 billion loss, while Moderna Merck reported positive trial results preventing melanoma recurrence. Argenx Vyvgart shares jumped on trial success for autoimmune drug, and pharma M&A strategies emphasize avoiding desperate deals. Rare disease trials are advancing for conditions affecting just 30 people worldwide, while student loans face worsened repayment terms for some borrowers.

Corporate Earnings & Retail

Fortescue profit fell despite buoyant iron ore prices as China challenges persist, while Carlsberg guidance lifted the lower end on nonalcoholic drink growth. TJX sales were hurt by self-inflicted issues despite discount retail resilience, and La-Z-Boy swung to a Q1 loss on 3% sales decline. Estée Lauder reported a 6.3% sales rise as turnaround efforts gain momentum, while Coty guidance forecasts a low- to mid-single-digit revenue decline. SharkNinja AI tools aim to monitor profitability in real time, and TrueCar CEO warns of auto industry peril amid trade uncertainty.